Chelsea Counsel Company’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$114K Sell
1,500
-20
-1% -$1.43K 0.05% 110
2025
Q4
$94.6K Hold
1,520
0.04% 110
2025
Q3
$90.1K Buy
1,520
+50
+3% +$2.91K 0.04% 116
2025
Q2
$86.4K Hold
1,470
0.04% 117
2025
Q1
$73.8K Hold
1,470
0.04% 119
2024
Q4
$66.6K Sell
1,470
-4,220
-74% -$200K 0.03% 121
2024
Q3
$277K Sell
5,690
-60
-1% -$2.89K 0.14% 89
2024
Q2
$296K Sell
5,750
-5,335
-48% -$292K 0.15% 86
2024
Q1
$608K Sell
11,085
-650
-6% -$33.9K 0.34% 49
2023
Q4
$667K Sell
11,735
-6,855
-37% -$387K 0.35% 55
2023
Q3
$1.16M Buy
18,590
+8,410
+83% +$532K 0.6% 37
2023
Q2
$607K Sell
10,180
-1,350
-12% -$85.9K 0.3% 67
2023
Q1
$858K Buy
11,530
+250
+2% +$19.3K 0.42% 53
2022
Q4
$829K Sell
11,280
-1,940
-15% -$153K 0.41% 54
2022
Q3
$1.1M Sell
13,220
-640
-5% -$55.1K 0.68% 38
2022
Q2
$1.1M Buy
13,860
+170
+1% +$16.5K 0.57% 42
2022
Q1
$1.42M Sell
13,690
-200
-1% -$16.6K 0.63% 42
2021
Q4
$1.04M Buy
13,890
+8,715
+168% +$610K 0.45% 50
2021
Q3
$335K Buy
+5,175
New +$316K 0.15% 76

Other funds holding NTR

Chelsea Counsel Company's NTR Position: Q1 2026 in Review

Chelsea Counsel Company reduced its Nutrien (NTR) stake by 1.3% in Q1 2026, selling an estimated $1.43K and leaving 1,500 shares worth $114K. The position accounts for 0.05% of the portfolio, ranked #110.

Chelsea Counsel Company first reported a position in NTR in Q3 2021 and has held it in 19 quarters since. The position peaked at $1.42M in Q1 2022. 748 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

  • Chelsea Counsel Company held 1,500 shares of Nutrien worth $114K as of Q1 2026.
  • Chelsea Counsel Company sold 20 Nutrien shares in Q1 2026, an estimated $1.43K.
  • Nutrien made up 0.05% of Chelsea Counsel Company's portfolio in Q1 2026, its #110 holding.
  • Chelsea Counsel Company first reported a position in Nutrien in Q3 2021 and has held it in 19 quarters since.
  • Chelsea Counsel Company's Nutrien position peaked at $1.42M in Q1 2022.
  • 748 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on Chelsea Counsel Company's 13F filing for Q1 2026, filed 24 Apr 2026.